Draft guideline on influenza vaccines – quality module

  • Email
  • Help

Document details

Download document Draft guideline on influenza vaccines – quality module
Reference number EMA/CHMP/BWP/310834/2012
Status draft: consultation closed
First published 2013-03-08
Last updated 2013-03-08

Summary

The purpose of this guideline is to provide guidance on development, manufacturing and control for marketing-authorisation applications for influenza vaccines. The quality module has been updated in the light of experience gained during the recent influenza pandemic and also consolidates the current existing guidelines for influenza vaccines.